NCT02104791

Evaluation of the Role of Plasma Procalcitonin in Prediction of Intra-amniotic Infection in Preterm Premature Rupture of Membrane

Procalcitonin Has a Role to Play in Prediction of Intra-amniotic Subclinical Infection.

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 100 (actual)
• Sponsor: Ain Shams Maternity Hospital · Academic / Other
• Sex: Female
• Age: 20 Years – 40 Years
• Healthy volunteers: Accepted

Summary

It is hypothesized that the procalcitonin has a role to play in prediction of intra-amniotic subclinical infection.

Detailed description

Study population * This study will be conducted at the department of Obstetrics and Gynecology recruiting pregnant women selected from the attendees of antenatal clinic, emergency department and from inpatient wards of Ain Shams University Maternity Hospital from Mars2014. * This study will include 100 pregnant women these cases will be divided into 2 groups: * Group 1: Healthy preterm Group: will include 50 pregnant females all at 24-34 weeks of gestational age . * Group 2: Preterm premature rupture of membrane Group: will include 50 pregnant females all at 24-34 weeks of gestational age

Conditions

• Intra-amniotic Subclinical Infection.

Interventions

Type	Name	Description
DRUG	procalcitonin	In patient with preterm premature rupture of membrane (PPROM) is the procalcitonin can be used to predict intra-amniotic subclinical infection?

Timeline

• Start date: 2014-05-01
• Primary completion: 2015-05-01
• First posted: 2014-04-04
• Last updated: 2014-04-04

Locations

1 site across 1 country: Egypt